Concepedia
Publication | Open Access
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study
119
Citations
21
References
2017
Year
MedicineMast Cell DisorderAllergyScleroderma
Page 1